ITC Refuses To OK Amgen, Roche Anemia Drug Deal
The U.S. International Trade Commission on Wednesday finally dropped its investigation into a patent fight between Amgen Inc. and Roche Holding Ltd. over an anemia drug after their 2009 settlement, but...To view the full article, register now.
Already a subscriber? Click here to view full article